IL17A and metabolic dysfunction-associated steatotic liver disease: In sum, we show a novel role for IL-17F signaling in NAFLD pathogenesis along with a role for IL-17RA and IL-17A in MCDD-driven NAFLD, and provide initial evidence for the critical IL-17RA expressing cells and the cells producing its signaling ligands.